Safety and Efficacy of OCN19-overexpressed Human Umbilical Cord-derived Mesenchymal Stem Cells in the Treatment of Refractory Type 2 Diabetes Mellitus

NCT06727721 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Diabetes
Type 2 Diabetes

Interventions

BIOLOGICAL: mesenchymal stem cells with OCN-19
BIOLOGICAL: Mesenchymal stem cells
BIOLOGICAL: albumin injection

Sponsor

Lu jin ，MD